Scientific Program
 
Scientific ProgramSearch Abstract
 
Session
 
Myeloproliferative disorders - Biology & Clinical
Date: Saturday, 06 June 2009
Time:18:00-19:15
Room:
 
18:00-19:15
CONSISTENT UP-REGULATION OF STAT3 INDEPENDENTLY OF JAK2 MUTATIONS IN A NEW MURINE MODEL OF ESSENTIAL THROMBOCYTHEMIA 0888
Rinaldi, Ciro Roberto, Senyuk, Vitaly, Rinaldi, Paola, Rotoli, Bruno, Pane, Fabrizio, Nucifora, Giuseppina (Naples, Italy)
 
18:00-19:15
ELEVATED PRV-1 PLASMA LEVEL IS A RISK FACTOR FOR TRANSIENT ISCHEMIC ATTACK (TIA) IN ESSENTIAL THROMBOCYTHEMIA (ET) 0889
Schwemmers, Sven, Maerz, Edith, Gisslinger, Heinz, Schneider, Friederike , Pahl, Heike L. (Freiburg, Germany)
 
18:00-19:15
INCREASED EXPRESSION OF THE ATP9A GENE IN ESSENTIAL THROMBOCYTHEMIA 0890
Vaz, Andreia, Silva, Elizabeth, Silva, Maria, Paixão, Eleonora, Pereira, Ana, Lúcio, Paulo, António, Ana, Jordan, Peter, Vieira, Luís (Lisboa, Portugal)
 
18:00-19:15
SOCS3 TYROSINE PHOSPHORYLATION AS A BIO-MARKER FOR THE MYELOPROLIFERATIVE DISORDER-ASSOCIATED MUTANT JAK2 KINASES 0891
Nahlik, Krystyna, Elliott, Joanne, Suessmuth, Yvonne, Scott, Linda, McMullin, Mary, Constantinescu, Stefan, Green, Anthony, Johnston, James (Belfast, United Kingdom)
 
18:00-19:15
CONCURRENT JAK2 V617F MUTATION AND BCR-ABL REARRANGEMENT IN A ESSENTIAL THROMBOCYTHEMIA PATIENT 0892
Novella, Elisabetta, Bernardi, Martina, Pomponi, Fabrizio, Peotta, Eleonora, Rodeghiero, Francesco (VICENZA, Italy)
 
18:00-19:15
NATURAL EVOLUTION OF JAK2V617F ALLELE BURDEN IN POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA PATIENTS NOT RECEIVING CYTOREDUCTIVE TREATMENT 0893
Besses, Carlos, Alvarez-Larran, Alberto, Martínez-Avilés, Luz, Longarón, Raquel, Serrano, Sergi, Bellosillo, Beatriz (Barcelona, Spain)
 
18:00-19:15
POLYCYTHEMIA VERA (PV) BUT NOT ESSENTIAL THROMBOCYTHEMIA (ET) REDUCES THE LIFE EXPECTANCY IN ELDERLY 0894
Tezza, Fabiana, Ruzzon, Elisabetta, Zambon, Sabina, Manzato, Enzo, Fabris, Fabrizio, Randi, Maria Luigia (Padua, Italy)
 
18:00-19:15
ANALYSIS OF BONE MARROW PATHOLOGY, ANGIOGENESIS AND CLINICAL PARAMETERS IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE DISORDERS 0895
Zhelyazkova, Antonina, Gercheva, Liana, Kolova, Penka, Tonchev, Anton (Varna, Bulgaria)
 
18:00-19:15
THY-1, C-KIT AND TFR EXPRESSIONS ON CD34 MYELOBLASTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND THEIR RELATIONS TO IPSS 0896
Atfy, Maha (Zagazig, Egypt)
 
18:00-19:15
LANGERHANS CELL HISTIOCYTOSIS IN CHILDREN - DIAGNOSIS, TREATMENT AND FOLLOW-UP 0897
Glamocanin, Sofijanka, Muratovska, Olivera, Martinova, Kata, Trajkova-Antevska, Zorica, Conevska, Biljana, Koceva, Svetlana, Petrusevska, Gordana (Skopje, Macedonia)
 
18:00-19:15
THROMBOSIS IN POLYCYTHEMIA VERA (PV) ARE LIKELY TO BE RELATED TO HIGHER JAK2V617F ALLELE BURDEN 0898
Bertozzi, Irene, Scapin, Margherita, Tezza, Fabiana, Scandellari, Raffaella, Fabris, Fabrizio, Randi, Maria Luigia (Padua, Italy)
 
18:00-19:15
LEUKOCYTOSIS IS A RISK FACTOR FOR RECURRENT THROMBOSIS IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA 0899
De Stefano, Valerio, Za, Tommaso, Rossi, Elena, Vannucchi, Alessandro, Ruggeri, Marco, Elli, Elena, Micò, Caterina, Tieghi, Alessia, Cacciola, Rossella, Santoro, Cristina, Gerli, Giancarla, Vianelli, Nicola, Guglielmelli, Paola, Pieri, Lisa, Scognamiglio, Francesca, Rodeghiero, Francesco, Pogliani, Enrico, Finazzi, Guido, Gugliotta, Luigi, Leone, Giuseppe, Barbui, Tiziano (Rome, Italy)